-
-
-
-
-
-
-
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
-
-
-
-
-
-
-
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered
-
-
-
-
-
-
-
Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer
-
-
-
-
-
-
-
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
-
-
-
-
-
-
-
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration
-
-
-
-
-
-
-
Myriad Genetics Expands Partnership with Intermountain Precision Genomics to Add Liquid Biopsy Therapy Selection Offering to Portfolio of Precise™ Oncology Solutions
-
-
-
-
-
-
-
Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

